Search results
Optimizing production to save time, improve yield, and increase safety. Learn More. Discover Asymchem, a top CDMO serving global pharma companies with innovative green solutions, advanced drug development, and manufacturing services.
Asymchem has invested in a complete bio-enzyme catalysis technology platform supporting a library of more than 2300 enzymes, many used in the production of statins, glitazones, penem antibiotics and other
Asymchem Group | 11,683 followers on LinkedIn. A leading global CMC/CDMO providing fully integrated solutions in chemical-pharmaceutical and biologic sectors. | At Asymchem we are proud of the...
A leading global CMC/CDMO providing fully integrated solutions in chemical-pharmaceutical and biologic sectors. | At Asymchem we are proud of the strides that we have made since our founding in...
May 21, 2024 · Asymchem Laboratories is expanding its global footprint by taking on Pfizer’s leftovers in Sandwich, England. | Pfizer downsized much of its operations at the site, where it first discovered ...
At Asymchem, we know how to help biotech and emerging pharmaceutical companies get things done. We’ve gained our knowledge over 20 years as a CDMO, helping big pharma launch therapeutics.
Jan 11, 2022 · “Asymchem is honored to aid AUM in bringing therapeutic treatments to patients suffering from rare cancers by performing drug substance process development and manufacturing solutions,” stated Elut Hsu, President of Asymchem, Inc and SVP of BD for Asymchem Group.
May 21, 2024 · Asymchem will continue to operate the site in Sandwich, Kent, as a clinical small molecule development and manufacturing facility to meet global client demands for pharma services and supply. The...
May 21, 2024 · TEDA TIANJIN, China--(BUSINESS WIRE)--Asymchem Laboratories (Tianjin) Co., Ltd. (Stock Code 002821.SZ/6821.HK) announced today that it will operate the former Pfizer U.K. small molecule API...
May 23, 2024 · Making its entry into Europe, the Chinese pharmaceutical services firm Asymchem will take over as the operator of the former Pfizer small-molecule pilot plant in Sandwich, England.
